CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

被引：1
|
作者：
Liu, Wei [1 ]
Huang, Wenyang [1 ]
Lv, Rui [1 ]
Liu, Huimin [1 ]
Yi, Shuhua [1 ]
Liu, Hong [1 ]
Lv, Lulu [2 ]
Qiu, Lugui [1 ]
Wang, Jianxiang [1 ]
Zou, Dehui [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Juventas Cell Therapy Ltd, Tianjin, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167104
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4598 / 4599
页数：2
相关论文
共 50 条
  • [41] Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma
    Rejeski, K.
    Sesques, P.
    Berger, C.
    Jentzsch, L.
    Mougiakakos, D.
    Froelich, L.
    Bucklein, V
    Blumenberg, V
    Schmidt, C.
    Jallades, L.
    Fehse, B.
    Faul, C.
    Weigert, O.
    Dreyling, M.
    von Bergwelt-Baildon, M.
    Mackensen, A.
    Bethge, W.
    Ayuk, F.
    Bachy, E.
    Salles, G.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 45 - 46
  • [42] The promise of CAR T-cell therapy in aggressive B-cell lymphoma
    Nair, Ranjit
    Neelapu, Sattva S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (03) : 293 - 298
  • [43] CAR T-cell therapy in diffuse large B-cell lymphoma
    Hopfinger, Georg
    Worel, Nina
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 32 - 35
  • [44] CAR T-cell therapy in diffuse large B-cell lymphoma
    Georg Hopfinger
    Nina Worel
    memo - Magazine of European Medical Oncology, 2020, 13 : 32 - 35
  • [45] Long-Term Follow-Up of Anti-CD19 CAR T-Cell Therapy for B-Cell Lymphoma and Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 8 - 9
  • [46] Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany
    Skalt, Daniela
    Moertl, Bernhard
    von Bergwelt-Baildon, Michael
    Schmidt, Christian
    Schoel, Wolfgang
    Buecklein, Veit
    Weiglein, Tobias
    Dreyling, Martin
    Berger, Karin
    HEMASPHERE, 2022, 6 (07): : E736
  • [47] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    BLOOD, 2023, 142 (12) : 1047 - 1055
  • [48] CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome
    Chen, Liting
    Xu, Bin
    Long, Xiaolu
    Gu, Jia
    Lou, Yaoyao
    Wang, Di
    Cao, Yang
    Wang, Na
    Li, Chunrui
    Wang, Gaoxiang
    Wang, Ying
    Zhu, Li
    Wang, Jin
    An, Haiyun
    Xiao, Min
    Xiao, Yi
    Zhou, Jianfeng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [49] The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
    Lutfi, Forat
    Kansagra, Ankit
    Ali, Moaath Mustafa
    Bukhari, Ali
    Siglin, Jonathan
    Yan, Jingsheng
    Samanta, Santanu
    Holtzman, Noa G.
    Gottlieb, David
    Kim, Dong Won
    Lee, Seung-Tae
    Kocoglu, Mehmet Hakan
    Yared, Jean A.
    Hardy, Nancy M.
    Molitoris, Jason
    Mohindra, Pranshu
    Rapoport, Aaron P.
    Dahiya, Saurabh
    BLOOD, 2020, 136
  • [50] CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain
    Li, Tongjuan
    Zhao, Lei
    Zhang, Yuanyuan
    Xiao, Yi
    Wang, Di
    Huang, Liang
    Ma, Liya
    Chen, Liting
    Liu, Songya
    Long, Xiaolu
    Meng, Fankai
    Zhu, Xiaojian
    Wei, Jia
    Xu, Bin
    Zhou, Jianfeng
    Zhou, Xiaoxi
    FRONTIERS IN ONCOLOGY, 2020, 10
12345